EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BCG‐Related Immune Reconstitution Inflammatory Syndrome and Delayed Donor Chimerism After Allogeneic HSCT in T − B − NK + SCID: A Successful Report of Steroid‐Sparing Management

Seyed Reza Abdipour Mehrian iD, Sarah Ravankhah iD, Kiarash Kavari iD, Elahe Meftah, Hadis Jafarian iD, Somayeh Khajeh, Hadi Mottaghipisheh iD, Ali Amanati iD

Case Reports in Immunology · 2026-01 · 2026 (1)

DOI: 10.1155/crii/3971651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Immunology, online erschienen am 27.07.2026. Verfasst von Seyed Reza Abdipour Mehrian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Development Center, Amir Oncology Teaching Hospital, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe combined immunodeficiency (SCID) is a life‐threatening disorder that requires early hematopoietic stem cell transplantation (HSCT). In regions where Bacillus Calmette–Guérin (BCG) vaccination is routinely administered at birth, disseminated BCG disease significantly complicates the clinical course in infants. Post‐HSCT, immune reconstitution inflammatory syndrome (IRIS) poses an additional challenge, particularly in patients with active mycobacterial infections and mixed chimerism. Case Presentation We describe a female infant with T − B − NK + SCID who developed disseminated BCG disease after routine BCG vaccination. At 6 months, she underwent HSCT from an HLA‐matched sibling without a conditioning regimen, according to the EBMT/ESID guidelines for T − B − NK SCID. Donor chimerism was undetectable on two early occasions (days +14 and +28), initially raising concerns of graft failure. During this window, the patient developed paradoxical BCG‐related IRIS, progressive lymphadenitis, and fever, which ultimately coincided with the first emergence of donor cells rather than graft loss. Corticosteroids were withheld because of the risk of infection and rejection. Instead, escalation of multidrug antimycobacterial therapy (intensified by adding amikacin and clarithromycin) led to clinical improvement. Subsequent testing demonstrated stable mixed donor chimerism (21% at +40, 23% at +60, and 51% at 8 months) with progressive donor T‐cell reconstitution and the absence of graft‐versus‐host disease (GVHD). At the most recent follow‐up, ~16 months after HSCT, the patient remained clinically well.

Conclusion

This case highlights the diagnostic and therapeutic dilemmas in managing SCID patients with BCG disease after HSCT. Early negative chimerism does not always predict graft failure, and paradoxical IRIS should be considered when clinical deterioration coincides with immune recovery after HSCT. Our findings suggest that conservative corticosteroid‐sparing management with intensified antimycobacterial therapy may improve outcomes.

Schlagwörter

Stichwörter der Autor:innen

Bacillus Calmette–Guérin (BCG) diseasehematopoietic stem cell transplantationimmune reconstitution inflammatory syndromemixed chimerismsevere combined immunodeficiency

Autor:innen und Institutionen

  • Clinical Research Development Center, Amir Oncology Teaching Hospital, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.
  • Yasuj University of Medical Sciences, Yasuj, Iran, yums.ac.ir.
  • Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran, kmu.ac.ir.
  • Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.
  • Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.

ORCID-Profile: Seyed Reza Abdipour Mehrian, Sarah Ravankhah, Kiarash Kavari, Hadis Jafarian, Hadi Mottaghipisheh, Ali Amanati

Zitieren

APA

Mehrian, S. R. A., Ravankhah, S., Kavari, K., Meftah, E., Jafarian, H., Khajeh, S., Mottaghipisheh, H., & Amanati, A. (2026). BCG‐Related Immune Reconstitution Inflammatory Syndrome and Delayed Donor Chimerism After Allogeneic HSCT in T − B − NK + SCID: A Successful Report of Steroid‐Sparing Management. Case Reports in Immunology, 2026(1). https://doi.org/10.1155/crii/3971651

Vancouver

Mehrian SRA, Ravankhah S, Kavari K, Meftah E, Jafarian H, Khajeh S, et al. BCG‐Related Immune Reconstitution Inflammatory Syndrome and Delayed Donor Chimerism After Allogeneic HSCT in T − B − NK + SCID: A Successful Report of Steroid‐Sparing Management. Case Reports in Immunology. 2026;2026(1). doi:10.1155/crii/3971651

BibTeX
@article{Mehrian2026,
  author = {Mehrian, Seyed Reza Abdipour and Ravankhah, Sarah and Kavari, Kiarash and Meftah, Elahe and Jafarian, Hadis and Khajeh, Somayeh and Mottaghipisheh, Hadi and Amanati, Ali},
  title = {BCG‐Related Immune Reconstitution Inflammatory Syndrome and Delayed Donor Chimerism After Allogeneic HSCT in T − B − NK + SCID: A Successful Report of Steroid‐Sparing Management},
  journal = {Case Reports in Immunology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crii/3971651}
}
Kostenlos starten →